跳至主要内容
临床试验/JPRN-UMIN000010519
JPRN-UMIN000010519已完成未知

Impact of olopatadine hydrochloride(allelock(R)) against scratching behavior of atopic dermatitis patients at night. - Impact of olopatadine hydrochloride(allelock(R)) against scratching behavior of atopic dermatitis patients at night.

Mie University, Graduate School of Medicine0 个研究点目标入组 25 人开始时间: 2013年4月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Those who may be pregnant or possible pregnant. 2)Those who have critical renal dysfunction and an impaired liver function. 3)The person under the specific or nonspecific de-sensitization treatment. 4)Those who took or injected a steroid, methotrexate, and cyclosporin in two weeks of the test . 5)Those who took the antihistamine within one week before the trial. 6)Those who have been engaged in business, such as operation of the car or machine. 7)The patient who is under the treatment of PUVA therapy using photo-senstive pills. 8)The patient with hypersensitivity or a drug-induced organ injury in the past with the use of Olopatadine, such as a Olopatadine hydrochloride (areroc(R)) and eye-drops Patanol (R). 9)Have lactose intolerance. 10)The person who is unsuitable for the entry judged by a doctor.

研究者

发起方
Mie University, Graduate School of Medicine

相似试验